Comment on

• Quality-of-life effects of prophylactic salpingo-oophorectomy versus gynecologic screening among women at increased risk of hereditary ovarian cancer.

  Madalinska JB, Hollenstein J, Bleiker E, van Beurden M, Valdimarsdottir HB, Massuger LF, Gaarenstroom KN, Mourits MJ, Verheijen RH, van Dorst EB, van der Putten H, van der Velden K, Boonstra H, Aaronson NK. Madalinska JB, et al. J Clin Oncol. 2005 Oct 1;23(28):6890-8. doi: 10.1200/JCO.2005.02.626. Epub 2005 Aug 29. J Clin Oncol. 2005. PMID: 16129845
• Mammography, breast ultrasound, and magnetic resonance imaging for surveillance of women at high familial risk for breast cancer.

  Kuhl CK, Schrading S, Leutner CC, Morakkabati-Spitz N, Wardelmann E, Fimmers R, Kuhn W, Schild HH. Kuhl CK, et al. J Clin Oncol. 2005 Nov 20;23(33):8469-76. doi: 10.1200/JCO.2004.00.4960. J Clin Oncol. 2005. PMID: 16293877 Clinical Trial.
• Prospective study of breast cancer incidence in women with a BRCA1 or BRCA2 mutation under surveillance with and without magnetic resonance imaging.

  Warner E, Hill K, Causer P, Plewes D, Jong R, Yaffe M, Foulkes WD, Ghadirian P, Lynch H, Couch F, Wong J, Wright F, Sun P, Narod SA. Warner E, et al. J Clin Oncol. 2011 May 1;29(13):1664-9. doi: 10.1200/JCO.2009.27.0835. Epub 2011 Mar 28. J Clin Oncol. 2011. PMID: 21444874 Free PMC article. Clinical Trial.
• Online tool to guide decisions for BRCA1/2 mutation carriers.

  Kurian AW, Munoz DF, Rust P, Schackmann EA, Smith M, Clarke L, Mills MA, Plevritis SK. Kurian AW, et al. J Clin Oncol. 2012 Feb 10;30(5):497-506. doi: 10.1200/JCO.2011.38.6060. Epub 2012 Jan 9. J Clin Oncol. 2012. PMID: 22231042 Free PMC article.